DeutschNewstral
Article
Bbarrons.com on 2023-07-25 15:56
Biogen Stock Drops Despite News of Layoffs as Company Rolls Out Alzheimer's Drug 3 min read
Related news
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com
- BBiogen Stock Is Tumbling Because Its Alzheimer's Drug Rollout Isn't Going So Well2 min readbarrons.com
- BBiogen Partner Eisai Files for Accelerated Approval of Alzheimer's Drug2 min readbarrons.com
- MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min readmarketwatch.com
- BBiogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug 4 min readbarrons.com
- BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min readbarrons.com
- MBiogen shares tumble on Alzheimer's candidate datamarketwatch.com
- BBiogen Stock Drops as Results Fall Short. Sales of Alzheimer's Drug Disappoint.3 min readbarrons.com
- WAlzheimer's drug from Biogen, partner receives FDA approvalwraltechwire.com
Biogen reanalyzes studies, presses ahead on Alzheimer's druglasvegassun.com- BBiogen Announces New Trial for Alzheimer’s drug Aduhelm2 min readbarrons.com
- BBiogen Lifts Profit Estimates. The Stock Rises.1 min readbarrons.com
- MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decisionmarketwatch.com
- MBiogen Alzheimer's drug appears to have setback as FDA advisers recommend not to approvemarketwatch.com
- BBiogen Is Giving Away Its Controversial Alzheimer's Drug: Report 2 min readbarrons.com
- BBiogen to Eliminate Alzheimer's Drug Infrastructure, Search for New CEO1 min readbarrons.com
- BBiogen in Pole Position After Roche's Alzheimer's Drug Disappoints3 min readbarrons.com
- BBiogen Says EU Regulator Takes 'Negative Opinion' on Its Alzheimer's Drug1 min readbarrons.com
- BBiogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug2 min readbarrons.com